Lipitor, Zocor Pediatric Safety Surveillance Needs More Time, FDA Cmte. Says
Executive Summary
Pediatric safety surveillance for Pfizer's Zoloft and Lipitor should continue for another year, the Anti-Infective Drugs Pediatric Advisory Subcommittee advised FDA during a June 12 meeting